INOGEN EL ICD DR D142

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative report with the FDA on 2020-03-30 for INOGEN EL ICD DR D142 manufactured by Boston Scientific Corporation.

Event Text Entries

[185756373] It was reported that the patient received anti-tachycardia pacing (atp) and shock therapy from this implantable cardioverter defibrillator (icd) device. Information indicates this therapy was inappropriate as it was provided due to an atrial-driven arrhythmia. Device therapy was exhausted, and the patients rhythm never broke. Boston scientific technical services provided guidance to the boston scientific representative on possible device programming changes or to possibly consider use of rate control medications. The device remains in-service. No patient symptoms or adverse patient effects were reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2124215-2020-03595
MDR Report Key9901571
Report SourceCOMPANY REPRESENTATIVE
Date Received2020-03-30
Date of Report2020-03-30
Date of Event2020-01-28
Date Mfgr Received2020-01-29
Device Manufacturer Date2017-12-14
Date Added to Maude2020-03-30
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactTIMOTHY DEGROOT
Manufacturer Street4100 HAMLINE AVENUE NORTH
Manufacturer CitySAINT PAUL MN 55112
Manufacturer CountryUS
Manufacturer Postal55112
Manufacturer Phone6515826168
Manufacturer G1BOSTON SCIENTIFIC CLONMEL LIMITED
Manufacturer StreetCASHEL ROAD
Manufacturer CityCLONMEL
Manufacturer CountryEI
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameINOGEN EL ICD DR
Generic NameIMPLANTABLE DEVICE
Product CodeLWS
Date Received2020-03-30
Model NumberD142
Catalog NumberD142
Lot Number538875
Device Expiration Date2019-11-17
OperatorLAY USER/PATIENT
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerBOSTON SCIENTIFIC CORPORATION
Manufacturer Address4100 HAMLINE AVENUE NORTH SAINT PAUL MN 55112 US 55112


Patients

Patient NumberTreatmentOutcomeDate
10 2020-03-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.